Portfolio company
CryoLogyx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
CryoLogyx provides cryopreserved, assay-ready cell lines for researchers in the drug discovery, diagnostics and biotechnology sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Brink Biologics
This company supplies natural killer cell lines to pharmaceutical and biotechnology firms for laboratory testing and bioanalytical assay applications.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
BioCeros
This company provides cell line development services for monoclonal antibody production to biotechnology firms, pharmaceutical companies and academic institutions.
Clyde Biosciences
This company provides cardiac safety and efficacy testing services for pharmaceutical and biotechnology organisations using its proprietary cell-based assay platform.
LynxBiosciences
This biotechnology company develops cellular assays and microfluidic platforms to predict clinical drug responses for oncology patients and pharmaceutical developers.
Cryoveritas
Cryoveritas develops visual time-temperature indicators to monitor the integrity of biological samples and vaccines for research labs, biobanks, and logistics providers.
Vitricell
The company develops cryopreservation technology for researchers and clinics to preserve fragile cells and embryos using aseptic vitrification methods.
Axol Bioscience
This company supplies human induced pluripotent stem cells and reagents to biopharmaceutical and academic organisations for drug discovery and disease modelling.
